Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

Business Leaders

Aktuelle NewsUnternehmenMärkteWirtschaft & ForexRohstoffeZinssätzeBusiness LeadersInstitutionelle AnlegerTermineSektoren 
HomeAlle NewsMeistgelesene ArtikelBusiness Leaders Biografien
Portrait de Claudia Süssmuth Dyckerhoff
Alter : 54
Vermögen : 597 823 USD
Größte Unternehmen : Roche Holding AG - Ramsay Health Care Limited - Clariant AG
Übersicht 
Dr. Claudia Süssmuth Dyckerhoff is a Venture Partner at Qiming Venture Partners, focusing on healthcare investments. Claudia has been with McKinsey for 21 years in Europe, the US and for more than 10 years in Asia.

She became a Board member of Hoffmann-La Roche in May 2016, a Board member of Clariant in April 2016, a Board Member of Ramsay Health Care (international hospital operator) in November 2018 and she joined the QuEST Global board in November 2020. At Hoffmann-La Roche she is a member of the Corporate Governance and Sustainability Committee, at Clariant she is a member of the Compensation Committee and at Ramsay Health Care she is a member of the Risk Committee. For McKinsey, she remains in the role of a Senior Advisor.

She also supports two start-ups, and in September 2017 joined the board of Cyrcadia, a med tech start-up.

She joined McKinsey & Company in Switzerland 1995 with a transfer to the US focusing her work on supporting Healthcare companies - pharmaceutical/medical device companies, payor, provider and health systems in Europe and the US. In January 2006, she and her family transferred to China where she supported the buildup of the Healthcare sector – supporting Pharma and Med Tech companies in strategic as well as operative topics. As a Senior Partner, she took on the leadership of McKinsey’s Asia wide Health Systems and Services Sector serving healthcare companies as well as governments. Most of her recent work focuses on market entry or market growth strategies, business development, assessment of potential privatization assets in the health services arena, commercial excellence, organizational redesign and capability building, and operational performance improvement in hospitals. Claudia studied Business Administration at the University of St. Gallen, Switzerland as well as at ESADE, Barcelona where she graduated with an MBA.

She also holds a PhD in Business Administration from the University of St. Gallen/University of Michigan Ann Arbor.


Aktuelle Stellungen und Verantwortungsbereiche Claudia Süssmuth Dyckerhoff 
NameTitel Seit
Roche Holding AG
(Pharmazeutika)
Independent Non-Executive Director 2016
Ramsay Health Care Limited
(Gesundheitspflege Einrichtungen)
Non-Executive Director 2018
Clariant AG
(Chemie - spezialisiert)
Non-Executive Director 2016
F. Hoffmann-La Roche Ltd. Director 2018
Clariant International AG Non-Executive Director 2016
QuEST Global Services Pte Ltd. Director 2020
St. Gallen Foundation for International Studies Trustee -
Cyrcadia Ltd. Director -
Edugreen Education & Services Ltd. Director -
Qiming Venture Partners Ltd. Venture Partner -


Anteile an Claudia Süssmuth Dyckerhoff 
NameAktien%Wert
Clariant AG (CLN)
(Chemie - spezialisiert)
19 4880,0059%405 222 USD
Ramsay Health Care Limited (RHC)
(Gesundheitspflege Einrichtungen)
3 7050,0016%192 601 USD


Claudia Süssmuth Dyckerhoff: Persönliches Netzwerk 
Meistgelesene News 
11.01.JAMIE DIMON : JPMorgan's Dimon sagt, dass es 6-9 Monate dauern kann, bis sich das Wachstum der Verbraucherkredite wieder normalisiert
MR
14.01.ELON MUSK : Tesla-Waren können mit Dogecoin gekauft werden, sagt Musk in einem Tweet
MR
14.01.JACK DORSEY : Jack Dorseys Block will ein offenes Bitcoin-Schürfsystem aufbauen
MR
10.01.BRUNELLO CUCINELLI : Luxuskonzern Cucinelli verzeichnet 31% Umsatzplus im Jahr 2021
MR
07.01.CHRISTIAN KLEIN : Deutschlands Vorzeige-Tech-Konzern am Scheideweg
DP
07.01.TIM COOK : Apple-Chef Cook erhält für 2020 fast 100 Millionen Dollar
RE
12.01.MARTIN SORRELL : Sorrells S4 übertrifft die Prognosen bei weitem
MR
10.01.PAUL SCHULER : Jahresumsatz von 9,15 Milliarden Franken erwartet
AW
10.01.Estelle Brachlianoff wird nächste CEO von Veolia
MR
12.01.GORDON RISKE : Mit neuem Chef ins neue Jahr
DP
Weitere Nachrichten und Newsletter


© 2022 People and Ownership :   
Claudia Süssmuth Dyckerhoff : Verbindungen